USPTO serial 90532381
CLIPS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 5, 2022
- Examiner
- MCCARTHY, JOSEPH PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CLIPS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tara Reedy Sliva
Tara Reedy Sliva Dentons US LLPP.O. Box 1302Chicago, IL 60604United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Synthetic peptides for pharmaceutical purposes in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; Synthetic peptides for the treatment of cancer, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders ; pharmaceutical preparations based on peptides in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; Diagnostic kits consisting primarily of monoclonal antibodies or mimics thereof consisting of peptides, buffers, and reagents for use in disease testing; mimics consisting of peptides for antibodies | ACTIVE | Jun 30, 2009 |
| 042 | Inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical product development; pharmaceutical product evaluation; pharmaceutical research and development services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; identifying peptides in the nature of pharmaceutical research and development; optimalization of peptides and synthetic peptides in the nature of pharmaceutical research and development; research and development services in the field of synthetic peptides and other pharmaceutical preparations | ACTIVE | Jun 30, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOSYNTH B.V.
- Other trademarks owned by Pepscan Presto B.V.
- Other trademarks owned by Pepscan Presto B.V.
- Other trademarks owned by Pepscan Presto B.V.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CLIPS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 17, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 17, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 25, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 5, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 5, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 14, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2021 | NWAP | NEW APPLICATION ENTERED | — |